TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DETECTWISE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DETECTWISE

ST13

US500000088891709

Classe

9, 42, 44

Pedido

88891709

Registro

6715043

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

50

Atualização mais recente

19/05/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42, 44

Data de depósito

28/04/2020

Data de registro

03/05/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

03/05/2022

Última transação

03/05/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

04/05/2020

Primeiro uso no comércio

04/05/2020

Código do desenho

4

Tipo de titular

03

Localização do titular

Centreville, VA

Examinador

KUNG, KAELIE

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

P. C. (pessoa física)

Representantes

Blade Metzer Parsons Corporation, Legal

Classificação técnica

Classes Nice

Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Telethermographic testing systems sold as a unit comprised of thermal imaging cameras, infrared cameras, and computer hardware and recorded computer software for purposes of collecting, analyzing, and displaying information to help identify and prevent the spread of infectious diseases; biometric testing systems comprised of biometric scanners; systems comprised of downloadable electronic health assessment application questionnaires that use artificial intelligence analytics, downloadable and recorded computer software and user interfaces for end-users being touchscreens for electrotechnical and electronic devices, downloadable and recorded computer software that automates reporting, and risk analytics, to measure, analyze and detect indicia of, and possible exposure to, infectious diseases and viruses onsite at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities

Classe 42

Providing medical testing service in the field of infectious disease research and infectious disease classification to help prevent the spread of infectious diseases

Classe 44

Medical testing to assist in the diagnosis or treatment of infectious diseases, namely biological on-site testing; medical testing for diagnostic and/or reporting purposes; on-site medical testing for diagnostic or treatment purposes relating to infectious diseases, providing on-site medical testing and medical consultation facilities for preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by on-site medical laboratories for infectious diseases; on-site medical testing, namely, temperature testing, blood pressure testing, pulse rate testing and other testing for purposes of identifying and preventing the spread of infectious diseases; providing medical testing facilities utilizing telethermographic testing systems, providing medical testing facilities utilizing biometric testing systems, and testing centers located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; onsite virus testing at a mass scale, being medical testing for diagnostic or treatment purposes; providing on-site virus and infectious disease medical testing facilities with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing walk-up and drive-through infectious disease medical testing facilities; providing modular medical testing facilities for infectious diseases for use on site at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities; providing in-person health screening services and turn-key health assessment services at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying potential exposure to and carriers of infectious diseases and viruses and to prevent the spread of infectious diseases; providing modular facilities for on-site testing for infectious diseases for medical diagnostic or treatment purposes; providing mobile modular testing facilities for use in performing on-site testing for medical diagnostic or treatment purposes to prevent the spread of infectious diseases; providing modular testing facilities for on-site virus and infectious disease testing for medical diagnostic or treatment purposes with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing modular testing facilities for walk-up and drive-through infectious disease testing for medical diagnostic or treatment purposes, evaluation and analysis; providing modular testing facilities for infectious diseases for medical diagnostic or treatment purposes for use on site at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities; Providing mobile modular medical laboratory facilities to provide in-person infectious disease screening services for diagnostic purposes, and providing mobile modular sanitary installations with thermal imaging for dispensing antiseptic and antiviral agents for self-decontamination and for issuing personal protective gear, all located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

50 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/05/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/05/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/02/2022

PUBO

PUBLISHED FOR OPPOSITION

15/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/01/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/01/2022

GNRT

NON-FINAL ACTION E-MAILED

08/01/2022

CNRT

NON-FINAL ACTION WRITTEN

08/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/11/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/11/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/10/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

25/10/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

25/10/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

25/10/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

25/10/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

09/06/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/06/2021

GNRT

NON-FINAL ACTION E-MAILED

08/06/2021

CNRT

NON-FINAL ACTION WRITTEN

08/06/2021

IUAA

USE AMENDMENT ACCEPTED

08/06/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/05/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/05/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/05/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/05/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/05/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/05/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/05/2021

ALIE

ASSIGNED TO LIE

30/04/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

16/01/2021

IUAF

USE AMENDMENT FILED

16/01/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/01/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

15/01/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/09/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/09/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/09/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/09/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

17/07/2020

GNRT

NON-FINAL ACTION E-MAILED

17/07/2020

CNRT

NON-FINAL ACTION WRITTEN

17/07/2020

DOCK

ASSIGNED TO EXAMINER

13/07/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/05/2020

NWAP

NEW APPLICATION ENTERED

01/05/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DETECTWISE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.